Skip to search formSkip to main contentSkip to account menu

CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology

Known as: QS-WPAI-SHP TEST, WPAI01TN, Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Name 
Test names of questionnaire questions associated with the the version 2.0 of the work productivity and activity impairment specific health problem… 
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Clinically meaningful improvement in work productivity loss in active psoriatic arthritis: post-hoc analysis of SPIRIT-P1 and SPIRIT-P2 trials.
OBJECTIVES To determine the proportion of patients in Phase 3 studies (SPIRIT-P1 and SPIRIT-P2) who achieved minimal clinically… 
2019
2019
SAT0572 ANTINUCLEAR ANTIBODIES IN PRIMARY CARE SETTING: IS IT WORTH IT?
Background: Antinuclear antibodies (ANA) are the most frequently used screening tests for connective tissue diseases. However… 
2018
2018
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
Review
2018
Review
2018
SAT0316 Rapid and sustained improvements in both skin and musculoskeletal symptoms correlates with improved quality of life in patients with active psoriatic arthritis
Background Psoriatic arthritis (PsA) is a chronic, systemic, autoimmune, inflammatory arthritis condition commonly associated… 
Review
2017
Review
2017
SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors
Background Ixekizumab (IXE), a monoclonal high affinity antibody that selectively targets interleukin-17A, was superior to… 
2016
2016
Patient‐reported outcomes with the β3‐adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder
To assess patient‐reported outcomes (PROs) in patients with overactive bladder (OAB) receiving the novel β3‐adrenoceptor agonist… 
2016
2016
Abstract OT2-04-02: A non-interventional study to characterize the real world treatment patterns and outcomes of women with ER+, HER2- advanced or metastatic breast cancer in Italy
Background: Breast cancer is the most common type of cancer in women. There were an estimated 1.67 million new cases of breast… 
Highly Cited
2015
Highly Cited
2015
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study.
OBJECTIVE The aim of this study was to determine the extent to which structural damage, clinical disease activity, demographic… 
Review
2013
Review
2013
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study
2008
2008
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER
ABSTRACT Objective: Assess changes in resource utilization, work and activity impairment, and health utility among OAB patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)